Cardiovascular Outcome in Patients Treated With SGLT2 Inhibitors for Heart Failure: A Meta-Analysis

Background: Sodium–glucose co-transporter 2 (SGLT2) inhibitors are an emerging class of glucose-lowering drugs that have become increasingly relevant for the treatment and prevention of heart failure (HF). Therefore, we aimed to investigate various SGLT2 inhibitors in patients with established HF at...

Descripción completa

Detalles Bibliográficos
Autores principales: Gager, Gloria M., Gelbenegger, Georg, Jilma, Bernd, von Lewinski, Dirk, Sourij, Harald, Eyileten, Ceren, Filipiak, Krzysztof, Postula, Marek, Siller-Matula, Jolanta M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316592/
https://www.ncbi.nlm.nih.gov/pubmed/34336954
http://dx.doi.org/10.3389/fcvm.2021.691907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316592/
https://www.ncbi.nlm.nih.gov/pubmed/34336954
http://dx.doi.org/10.3389/fcvm.2021.691907

Ejemplares similares